ジェイファーマ株式会社 News Releases

J-Pharma and Uniphar Announce Strategic Partnership Milestone: Global Phase 3 Trial Initiation for JPH203 (nanvuranlat)

J-Pharma Co., Ltd. and Uniphar have jointly announced the initiation of a global Phase 3 clinical tr… · 2026-06-16

Notice Regarding Registration of Investigator-Initiated Clinical Trial (jRCT) for "Nanvuranlat" in Biliary Tract Cancer

J-Pharma Co., Ltd. announced that an investigator-initiated clinical trial evaluating the combinatio… · 2026-05-18